GoodRx Inc. (GDRX)
NASDAQ: GDRX
· Real-Time Price · USD
3.75
-0.07 (-1.83%)
At close: May 23, 2025, 3:59 PM
3.74
-0.13%
After-hours: May 23, 2025, 05:13 PM EDT
GoodRx Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 |
|---|---|---|---|---|---|
| Other Revenue Revenue | 21M | 20.05M | 20.43M | 92.14M | 62.44M |
| Other Revenue Revenue Growth | +4.74% | -1.83% | -77.83% | +47.56% | n/a |
| Prescription Transactions Revenue Revenue | 577.55M | 550.74M | 550.54M | 593.36M | 488.26M |
| Prescription Transactions Revenue Revenue Growth | +4.87% | +0.04% | -7.22% | +21.53% | n/a |
| Subscription Revenue Revenue | 86.54M | 94.41M | 96.17M | 59.92M | n/a |
| Subscription Revenue Revenue Growth | -8.34% | -1.83% | +60.48% | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 114.17M | 117.38M | 115.49M | 120.3M | 118.02M | 123.06M | 126.93M | 107.65M | 108.14M | 112.71M | 135.76M | 129.08M | 124.87M | 141.87M | 131.6M | 127.96M | 123.48M | 415.69M | 173.59M | 58.25M | 69.05M | 58.85M | 49.05M | 41.2M | 41.39M |
| Selling, General, and Administrative Revenue Growth | -2.73% | +1.64% | -4.00% | +1.93% | -4.09% | -3.05% | +17.91% | -0.46% | -4.05% | -16.98% | +5.18% | +3.37% | -11.98% | +7.80% | +2.84% | +3.63% | -70.30% | +139.47% | +198.00% | -15.64% | +17.32% | +19.98% | +19.06% | -0.45% | n/a |
| Research and Development Revenue | 31.14M | 31.74M | 30.14M | 30.85M | 31.02M | 31.53M | 39.61M | 31.29M | 32.91M | 36.77M | 35.92M | 35.4M | 35.04M | 35.06M | 35.07M | 29.57M | 26.16M | 23.68M | 15.85M | 11.96M | 10.32M | 9.82M | 7.84M | 6M | 5.82M |
| Research and Development Revenue Growth | -1.88% | +5.31% | -2.32% | -0.53% | -1.63% | -20.40% | +26.61% | -4.93% | -10.50% | +2.36% | +1.46% | +1.03% | -0.05% | -0.04% | +18.62% | +13.02% | +10.46% | +49.46% | +32.47% | +15.85% | +5.14% | +25.19% | +30.80% | +3.08% | n/a |
| Sales and Marketing Revenue | 84.54M | 93.83M | 89.87M | 93.45M | 89.96M | 93.75M | 91.61M | 80.46M | 78.52M | 84.13M | 86.22M | 94.34M | 92.95M | 106.49M | 95.65M | 88.38M | 79.69M | 74.94M | 65.11M | 51.92M | 63.16M | 54.33M | 44.95M | 37.77M | 38.84M |
| Sales and Marketing Revenue Growth | -9.90% | +4.41% | -3.84% | +3.88% | -4.04% | +2.33% | +13.86% | +2.47% | -6.66% | -2.42% | -8.61% | +1.49% | -12.72% | +11.33% | +8.23% | +10.90% | +6.34% | +15.09% | +25.41% | -17.80% | +16.26% | +20.86% | +19.02% | -2.78% | n/a |